% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{TauzideEspariat:301575,
author = {A. Tauziède-Espariat and V. Dangouloff-Ros and P.
Sievers$^*$ and M. Duchesne and A. Siegfried and Y. Nicaise
and N. Boddaert and L. Hasty and A. Métais and C. Ngo and
F. le Loarer and C. Bouvier and A. Fontaine and A. Rousseau
and F. Marguet and K. Beccaria and T. Blauwblomme and E.
Uro-Coste and P. Varlet},
collaboration = {RENOCLIP-LOC},
title = {{G}lioneuronal tumors {PATZ}1-fused: clinico-molecular and
{DNA} methylation signatures for a variety of morphological
and radiological profiles.},
journal = {Acta Neuropathologica Communications},
volume = {13},
number = {1},
issn = {2051-5960},
address = {London},
publisher = {Biomed Central},
reportid = {DKFZ-2025-01083},
pages = {114},
year = {2025},
abstract = {The neuroepithelial tumor, PATZ1-fused (NET-PATZ1), has
been recently isolated as a distinct methylation class by
DNA-methylation profiling and is characterized by recurrent
PATZ1 fusions, in association with the EWSR1 or MN1 genes
and a chromosome 22 chromothripsis. The clinical phenotype
is mainly pediatric and features circumscribed
supratentorial tumors. However, the histopathology is vastly
heterogeneous (glial, glioneuronal, sarcomatous,
multiphenotypic) and a cell of origin has not yet been
identified, explaining the previsionary imprecise
terminology of 'NET'. Moreover, extra-central nervous system
(CNS) sarcomas also harboring the EWSR1::PATZ1 fusion have
been reported and added to the current World Health
Organization (WHO) Classification of Soft Tissue and Bone
Tumors, in the chapter on undifferentiated small round cell
sarcomas. However, their relationship to their CNS
counterparts has not yet been studied. Herein, we analyzed a
cohort of twelve CNS tumors with PATZ1 fusions in terms of
clinical presentation, radiology, histopathology,
immunohistochemistry, ultrastructure and DNA-methylation
profiling and compared them to five extra-CNS
sarcomas-PATZ1. Based on the reported GATA2 overexpression
in NET-PATZ1, we also studied the potential interest of
GATA2 immunoexpression as a diagnostic tool. We confirmed
their distinct molecular characteristics and clinical
phenotype but evidenced a morphological intratumoral
heterogeneity with three recurrent morphological patterns
(oligodendroglial-like, pleomorphic xanthoastrocytoma-like
and spindle cells). Despite the unusual spindle and
proliferative component in a CD34 + glioneuronal tumor
(using electronic microscopy), these tumors present a
favorable prognosis. Their histopathological features were
all clearly distinct from their soft tissue counterparts.
GATA2 immunostaining is highly specific for CNS tumors
PATZ1-fused, but its sensitivity is perfectible and further
studies are needed to confirm its use as a diagnostic tool.
To conclude, our work highlights that CNS tumors,
PATZ1-fused seem to represent a novel pediatric glioneuronal
tumor type exhibiting a polymorphous morphology and provides
new support for its addition as a provisional emerging
pediatric circumscribed glioneuronal tumor type, low grade.},
keywords = {Humans / DNA Methylation: genetics / Male / Female / Child
/ Adolescent / Child, Preschool / Adult / Young Adult /
Repressor Proteins: genetics / Repressor Proteins:
metabolism / Neoplasms, Neuroepithelial: genetics /
Neoplasms, Neuroepithelial: pathology / Neoplasms,
Neuroepithelial: diagnostic imaging / Co-Repressor Proteins
/ Middle Aged / Central Nervous System Neoplasms: genetics /
Central Nervous System Neoplasms: pathology / Central
Nervous System Neoplasms: diagnostic imaging / Oncogene
Proteins, Fusion: genetics / RNA-Binding Protein EWS:
genetics / Infant / Kruppel-Like Transcription Factors /
DNA-methylation (Other) / EWSR1::PATZ1 (Other) /
Glioneuronal tumor (Other) / MN1::PATZ1 (Other) / PATZ1
protein, human (NLM Chemicals) / Repressor Proteins (NLM
Chemicals) / Co-Repressor Proteins (NLM Chemicals) /
Oncogene Proteins, Fusion (NLM Chemicals) / RNA-Binding
Protein EWS (NLM Chemicals) / Kruppel-Like Transcription
Factors (NLM Chemicals)},
cin = {B300 / HD01},
ddc = {610},
cid = {I:(DE-He78)B300-20160331 / I:(DE-He78)HD01-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40413488},
doi = {10.1186/s40478-025-02037-5},
url = {https://inrepo02.dkfz.de/record/301575},
}